Automated Western Blot Overcomes Modern Protein Analysis Bottlenecks
Automation is transforming protein analysis, enabling higher throughput, better reproducibility, and efficient use of limited samples.
As protein analysis workflows become increasingly central to drug discovery, gene therapy development, and translational research, laboratories are under pressure to deliver more data, at higher quality, and at greater speed—often from limited or precious samples. Traditional methods such as manual Western blotting remain widely used, but they struggle to keep pace with modern demands for throughput, reproducibility, and quantitative rigor.
In this article, Helen Hall, market development group manager, EMEA, at Bio‑Techne, shares where protein analysis workflows continue to bottleneck, how automated Western blot systems are reshaping experimental design, and which analytical capabilities will become essential as research moves toward higher throughput and tighter sample constraints.
Breaking throughput and variability bottlenecks in protein analysis
Where do you see the biggest bottlenecks in protein analysis today, and how are automated systems helping to remove those constraints?
According to Hall, many of today’s bottlenecks stem from the mismatch between legacy protein analysis methods and modern discovery workflows. In drug discovery, researchers routinely screen hundreds—or even thousands—of compounds during lead identification and optimization. Within these workflows, relative and quantitative protein expression data are often critical for understanding the mechanism of action and dose response.
Traditional Western blotting, however, struggles to meet these demands.
“Western blotting gives you the size specificity you need, but it’s manual, it takes one to two days, and it introduces a lot of variability,” Hall explained. “At best, you’re achieving semi‑quantitative results.”
Bio-Techne has introduced an automated capillary-based western analysis solution called Simple Western™ technology to address these issues. Simple Western delivers an end-to-end, hands-off workflow capable of processing up to 96 samples in approximately three hours on newer high-throughput instruments such as the Leo™ system. This makes size-resolved protein analysis practical in contexts where it was previously a limiting factor—including targeted protein degradation studies and potency screening in gene therapy development.
Key bottlenecks addressed through automation include:
- Manual handling steps that introduce variability
- Long run times incompatible with high-throughput screening
- Limited quantitative rigor in traditional Western blotting
- Difficulty scaling protein analysis in translational workflows
Workflow transformation: From manual intervention to closed automation
Which workflow steps see the biggest improvements when labs move from manual to automated Western blot systems?
Hall emphasized that even partially automated or “semi‑automated” Western blot workflows still depend heavily on manual intervention. Every intervention step—gel handling, transfers, washes, imaging—adds time, variability, and reliance on operator skill.
By contrast, Leo operates as a closed, end-to-end system, eliminating these points of intervention. “Once you press go, that’s it. Your time in the lab is done,” Hall said. “You can actually leave the site entirely and analyze the data remotely.”
Beyond speed, workflow improvements extend to data handling and regulatory compliance. Automated analysis removes subjective interpretation and manual image processing. Hall also highlighted support for 21 CFR Part 11 compliance, enabling full traceability of each analysis step—critical for regulated environments.
Another important advantage is assay transferability. End-to-end automation makes it significantly easier to reproduce assays across laboratories, supporting scale-up and cross-site collaboration.
Workflow improvements enabled by automation include:
- Reduced hands-on time and faster turnaround
- Elimination of manual interpretation and image manipulation
- Improved data security, traceability, and regulatory compliance
- Easier transfer of validated assays between labs
Designing for consistency, sensitivity, and sample conservation
What design features most directly improve consistency, sensitivity, and accuracy in automated protein analysis?
At the core of Simple Western technology is a closed cartridge, microfluidic system. “The instrument itself never touches the sample,” Hall explained. “Everything happens inside a single-use capillary.”
This architecture delivers several advantages at once. According to Hall, the closed system eliminates the need for cleaning or decontamination, reduces hazardous waste, and prevents cross-contamination. Microfluidics also dramatically lowers sample requirements, enabling picogram-level sensitivity from as little as three microliters of sample.
Bio-Techne’s proprietary chemistry binds proteins to the capillary wall, allowing efficient antibody removal and re-probing of the same proteins. This enables normalization or additional immunodetection by re-sampling from the same well—a major benefit when working with limited material.
Accelerate your PROTACs drug discovery and development
This eBook shows how an integrated, end-to-end analytical approach helps labs generate reliable, regulatory-ready PROTAC data at every stage of development.View eBook
Hall also highlighted reproducibility metrics, noting intra‑assay coefficients of variation of less than 15%, supporting confidence in quantitative measurements.
Key design features driving data quality:
- Closed, single-use cartridge architecture
- Microfluidics enabling high sensitivity from minimal sample sizes
- Efficient re-probing for normalization and quantitative accuracy
- Reduced waste and no instrument decontamination requirements
Integrating automated protein analysis into broader lab ecosystems
How does this automated solution integrate with existing LIMS, robotics, or laboratory workflows?
As automation expands across the lab, integration becomes essential. Simple Western’s short plate pipetting protocol can be scripted in collaboration with many liquid handling providers, allowing further automation of the small amount of sample preparation required prior to analysis.
Data accessibility is another key integration benefit. Once a run is initiated, users can access completed datasets remotely—supporting flexible work patterns and reducing the need for staff to remain on‑site during analysis.
Benefits of integrated, automated protein analysis:
- Compatibility with existing liquid handling platforms
- Potential for further upstream workflow automation
- Remote access to completed run data
- Minimal disruption to established lab infrastructure
What must protein analysis deliver next?
Looking ahead, which analytical capabilities or automation features will become essential for protein analysis?
Looking to the future, Hall sees several requirements becoming non-negotiable for protein analysis workflows.
Advancing Host Cell Protein Characterization With Proteomics
Drawing on real-world case studies from industry, attendees will learn practical approaches for achieving deeper proteome coverage, improved quantitative performance, and more robust HCP profiling across complex biopharmaceutical samples.View Webinar
First is size resolution at scale—the ability to quantify protein expression while distinguishing between intact, modified, or degraded forms. This is increasingly important in drug discovery and targeted protein degradation strategies.
Second is robust assay transferability, both within and between organizations. As collaborative and multi‑site research becomes more common, workflows must move with the assay—not stay locked to individual labs.
Finally, Hall emphasized sample conservation. In many therapeutic areas, patient-derived samples are extremely limited. Extracting meaningful, reproducible data from just one or two microliters of material is no longer a nice-to-have—it is essential.
“We can’t rely on needing 25 microliters of patient sample for traditional methods that are unreliable and open to variation,” she said.
Capabilities shaping the future of protein analysis:
- High throughput, size-resolved quantitation
- Transferable, automation-ready assays
- Maximizing data yield from minimal sample volumes
As protein analysis workflows evolve to meet the demands of modern drug discovery and translational research, automation is playing a critical role in removing long‑standing constraints around throughput, variability, and sample handling.
Key takeaways:
- Automated Western blot enables size-resolved, quantitative protein analysis at throughput levels unattainable with manual methods.
- Simple Western systems improve consistency, sensitivity, and sample conservation while reducing waste and hands-on time.
- Future protein analysis workflows will depend on scalability, assay transferability, and the ability to extract robust data from increasingly limited samples.
This content includes text that has been created with the assistance of generative AI and has undergone editorial review before publishing. Technology Networks' AI policy can be found here.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
